• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    High Drug Loading Amorphous Solid Dispersions

    Parenteral Drug Delivery Trends

    Selecting the Right Outsourcing Model for Emerging Biotech

    Inhaled Drug Delivery Technology

    The Future of Biologics: Accelerating Production, Reducing Costs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Fusion Pharmaceuticals Acquires IPN-1087

    Strata Oncology Unveils Strata PATH Trial

    Alimentiv Acquires McDougall Scientific

    Q BioMed Inks Strontium89 Supply Pact

    PCI Pharma Services Appoints SVP, CFO
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    WuXi AppTec Completes OXGENE Acquisition

    Celonic Group Announces Plans for New Facility in Switzerland

    BMS Expands Cell Therapy Manufacturing Capabilities

    Novo Nordisk Invests $80M in Tablet Production

    Arcline Investment Acquires ChargePoint Technology
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Reshaping the Pharmaceutical Supply Chain

    Covectra Introduces Next-Gen Serialization Solution

    Bormioli Opens New Glass Research Center

    Centrient Pharmaceuticals to Acquire Astral SteriTech

    Seasonal Vaccine Manufacturing
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Strata Oncology Unveils Strata PATH Trial

    Alimentiv Acquires McDougall Scientific

    WuXi AppTec Completes OXGENE Acquisition

    Live Webinar - Formulation Strategies for Poorly Soluble Molecules

    Celonic Group Announces Plans for New Facility in Switzerland
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Guide to Maintaining Validation of Older Facilities: Why, When and How

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Emergent BioSolutions

    Federal Equipment Company

    Syngene

    Baxter BioPharma Solutions

    Reed-Lane
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Baxter BioPharma Solutions

    PCI Pharma Services

    Federal Equipment Company

    Alcami

    Reed-Lane
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Ensuring Quality During the Transfer and Scale Up of Rx Drugs

    Defining the key parameters and considerations for a successful technology transfer.

    Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    Related CONTENT
    • Embedding Your Drug Strategy Within a Solid Foundation for Success
    • 20th Annual Contracting & Outsourcing Conference & Exhibition
    • Erfo
    • Corealis Pharma
    • Albemarle Corporation
    Tom Chang, President, Bora Pharmaceutical Laboratory Co. Ltd.11.17.20
    The demand for the services of contract development and manufacturing organizations (CDMOs) has never been higher, with approximately 28% of the world’s prescription and non-prescription drugs being manufactured by an outsourcing partner.1

    The growing use of CDMOs is being driven by the logical need of the industry: large pharma companies can divest non-core manufacturing facilities and focus capital instead on core products, while smaller companies often require the specialist services CDMOs offer to produce increasingly complex drugs cost effectively. For both small and large companies, partnering also allows for the reduction of risk, the management of costs, and ensuring the quality of the manufactured product.

    The importance of the right partnership
    The outsourcing partnership is one based on trust and begins with the technology transfer. When the pharmaceutical company transfers the required IP, the partner receives crucial technical and scientific information, which will allow for the manufacture of a product at a new manufacturing site. The formulation, manufacturing process, analytics, and packaging IP, as well as additional relevant documentation, knowledge, and professional expertise change hands in the process.

    If the technology transfer is handled badly, issues and risks can be introduced all the way through the process. There can be problems with the initial batches, analytical testing, packaging, and potentially patient safety. As a result, it is essential that extra time and effort is taken to outline all relevant parameters, so that product quality does not become an issue and, if it does, that there are adequate warnings. In this article we outline the key parameters and considerations to take into account, to ensure a successful technology transfer.

    Robust risk assessment
    First, it’s critical to conduct a thorough feasibility evaluation at the outset of the technology transfer. A risk assessment should cover all activities included in the technology transfer, where the contracted partner challenges assumptions, offers practical solutions and offers a range of value-based options to address and mitigate potential issues. A good outsourcing partner can identify problems from formulation issues during scale up to spotting regulatory incompatibilities early into the process.

    The more rigorously a process is challenged in the feasibility stage, the more robust that process will be during the scale up, validation, and commercial production phases. The technology transfer may not always be a smooth transition, especially when working with complex oral solid dose drugs, for example, but robust risk assessment is one way to ensure a quality end product.

    Communication is key
    When a technology transfer is executed successfully, both partners stand to gain in terms of time saved and costs minimized, while product quality is improved and performance risk is reduced. Communication to ensure this happens is central to the working relationship.

    Technology transfer is a person-to-person, system-to-system knowledge transfer. In line with this, the better the exchange and communication of information, the greater the likelihood of successfully fulfilling the program’s financial and commercial goals. It is important for sponsors to provide all relevant information, including ‘tribal’ knowledge, in a secure, defined space where the respective organizations can collaborate to develop practical solutions and ensure a robust technical transfer package.

    Three questions
    When choosing an outsourcing partner, it’s worth considering the following questions first:
    • Do they have a similar experience in scaling up similar processes?
    • Are they capable of exploring the design space of parameters and identifying the critical process parameters before scaling up?
    • Can they offer appropriate equipment to scale up and do they have the appropriate knowledge to scale up?

    Critical Quality Attributes (CQA)
    The technical transfer package is not complete until it provides Product Quality Attributes: Critical Quality Attributes (CQAs) and material attributes. A CQA appraisal will include an overview of processes, including unit operations, a control strategy, manufacturing process parameters, continuous improvement ideas and plans, historical deviations lists, and equipment and analytical technology lists.

    SUPAC
    Changes are often made to the manufacturing process after a drug is approved, from the equipment involved to the location of the site itself, or even the composition of the product. These are known as Scale-Up and Post Approval Changes (SUPAC). Any changes made can have an impact on the raw materials involved, manufacturing process, equipment train, manufacturing site, and the batch size. In turn, this can affect the CQAs of a drug or a finished product.

    It is, therefore, necessary to consider in advance the impact of any changes on the quality of a drug or finished product.

    SUPAC guidances provide those sponsors of new drug applications (NDAs) and abbreviated new drug applications (ANDAs) recommendations on the following: post-approval changes to components or compositions; the site of manufacture; the scale up/scale down of manufacture; and the manufacturing (process and equipment) of an immediate release oral formulation.

    All in the analytics
    The manufacturing process requires precise controls to ensure the quality of a drug throughout its lifecycle.

    For example, at Bora Pharmaceuticals we utilize a wide range of analytical tools to support product quality, which is especially important to ensure commercial products meet the requirements of regulators and the patients themselves. This involves using Design of Experiments (DoE), risk assessment platforms, and Process Analytical Technologies. Through the utilization of such tools, a design space can be created between partners where the CQA can meet predetermined specifications during technology transfer and scale up activity.

    Through analytical tools and when a sponsor provides reliable process knowledge, the contract manufacturing partner can establish a Normal Operating Range during technology transfer or a scale up activity.

    Engineering runs
    Before the scale up process, engineering (or demonstration) runs are the proving ground for the process and the equipment used during production. A successful engineering run is invaluable to ensure quality in subsequent current good manufacturing practice (cGMP) and packaging runs.

    The engineering run is carried out on the commercial equipment train to gather data (including stability) and perform filling and packaging line trials. It also provides the processing data that can then be used in the scale up and validation steps to follow.

    Since collecting this data is critical, at least one engineering run should be completed, with the risk of additional costs and delays if this step is neglected.

    Scale up
    Scale up is the process by which batch sizes are increased from feasibility or engineering batch scale to commercial scale, usually representing a 5-10x increase in volume.
    Knowledge should be gained on two factors during this process: acquiring the chemistry and process knowledge to be able to effectively manage the formulation at commercial scale and developing a strategy to manage production and material costs.

    Project and program management
    An experienced project and program management team is an essential element in ensuring that challenges at the later stages of the process can be managed. Working together with sponsors has allowed our team at Bora to navigate hurdles that have arisen once a product has been submitted for approval to regulators.

    In one example, Bora worked with a long-standing client on a complex modified-release capsule product with several different components. Once the product was submitted to the U.S. FDA for approval, an issue arose regarding capsule filling equipment not being able to measure individual component weights, which was deemed by the agency to be a necessary control parameter. The team at Bora organized a joint project group with the partner to develop potential solutions, resulting in a change to a more suitable capsule filling machine. The FDA agreed to the changes and the product was successfully approved and commercialized.

    Key takeaways
    We’ve provided a lot of information, but ultimately the three takeaway points to ensure a successful tech transfer are:
    • Communicate openly and frequently from the outset through planned meetings with solid record keeping
    • Establish working processes and take time with the initial planning stages
    • Maintain a partnership based on trust and respect to ensure success with each transfer and program 

    References
    1. https://www.pharmavoice.com/digital-edition/january-2020/#1


    Tom Chang is the President of Bora Pharmaceuticals Laboratory Co. Ltd. and oversees two manufacturing sites for Bora Pharmaceuticals. He has over 27 years’ experience in the pharmaceutical industry and over 14 years’ experience as a site general manager for multinational companies including Wyeth, Pfizer, and Impax. He has extensive knowledge and experience in global supply chain and operational management. Tom has outstanding leadership and professional skills and seeks to provide the highest quality products for his customers. He is a critical part of the leadership team at Bora Pharmaceuticals, a premier international CGMP CDMO specializing in oral solid dosage, liquids (solutions, suspensions, and nasal sprays), and semi-solids (creams and gels) pharmaceutical Rx and OTC products for late-phase clinical through commercial manufacturing and packaging. For more information visit: info@bora-corp.com
    Suggested For You
    Embedding Your Drug Strategy Within a Solid Foundation for Success Embedding Your Drug Strategy Within a Solid Foundation for Success
    20th Annual Contracting & Outsourcing Conference & Exhibition 20th Annual Contracting & Outsourcing Conference & Exhibition
    Erfo Erfo
    Corealis Pharma Corealis Pharma
    Albemarle Corporation Albemarle Corporation
    Lonza Capsules and Health Ingredients Lonza Capsules and Health Ingredients
    PCI Pharma Services PCI Pharma Services
    Catalent Pharma Solutions Catalent Pharma Solutions
    Bora Pharmaceuticals Bora Pharmaceuticals
    Ology Bioservices, Inc. Ology Bioservices, Inc.
    CureVac and Wacker Sign Contract for Manufacturing of Covid-19 Vaccine Candidate CureVac and Wacker Sign Contract for Manufacturing of Covid-19 Vaccine Candidate
    Lonza and Be The Match BioTherapies Enter CGT Partnership Lonza and Be The Match BioTherapies Enter CGT Partnership
    Samsung Biologics Breaks Ground on Samsung Biologics Breaks Ground on 'Super Plant'
    ApiJect Systems Approved for $590 Million Loan ApiJect Systems Approved for $590 Million Loan
    Syngene and 3DC Sign 5-year Collaboration Syngene and 3DC Sign 5-year Collaboration

    Related Features

    • Solid Dosage/Creams/Ointments
      High Drug Loading Amorphous Solid Dispersions

      High Drug Loading Amorphous Solid Dispersions

      A Novel Tablet Architecture for Amorphous Solid Dispersions to Achieve High Drug Loadings
      Deanna Mudie and Aaron Stewart, Lonza 01.27.21

    • Parenterals
      Parenteral Drug Delivery Trends

      Parenteral Drug Delivery Trends

      A Q&A with Lubrizol Life Science Health’s CDMO Division President, Rob Lee.
      Kristin Brooks, Managing Editor, Contract Pharma 01.27.21

    • Selecting the Right Outsourcing Model for Emerging Biotech

      Selecting the Right Outsourcing Model for Emerging Biotech

      Flexible outsourcing models help drive quality, control costs and enable better efficiencies and faster delivery.
      Timothy King and Elisha Talley-Roithner, PPD 01.27.21


    • Drug Delivery
      Inhaled Drug Delivery Technology

      Inhaled Drug Delivery Technology

      The success of any new inhaled medicine relies in a large part on the correct combination of formulation and device technology being chosen for its delivery.
      Dr. Sandy Munro, Vice President – Pharmaceutical Development, Vectura 01.27.21

    • Biologics, Proteins, Vaccines
      The Future of Biologics: Accelerating Production, Reducing Costs

      The Future of Biologics: Accelerating Production, Reducing Costs

      Yeast-based gene expression offers pharma the yield and efficiencies it needs to make pandemic-stopping vaccines faster and more economical.
      Mark Emalfarb, Dyadic 01.27.21

    • Analytical Services | Information Technology | Laboratory Testing
      Business Intelligence For (and From) the Lab

      Business Intelligence For (and From) the Lab

      How a digital ecosystem can harness the most data-rich environment in the CDMO.
      Bob Voelkner, VP Sales and Marketing, LabVantage 01.27.21


    • Communicating Your Contracting Priorities to Your Drug Company Customers

      Communicating Your Contracting Priorities to Your Drug Company Customers

      A discussion with Perrigo’s senior legal counsel, Susan Fyan, about issues that arise in very fact-specific contract negotiations between CDMOs and sponsors.
      Stephen Sayre, Dykema 01.27.21

    • COVID-19 Impact Report

      COVID-19 Impact Report

      Leaders across the pharmaceutical contract services industry reflect on the impact of COVID-19 in 2020, and what to expect in 2021.
      Tim Wright, Editor, Contract Pharma 01.27.21

    • Biologics, Proteins, Vaccines | Regulatory Affairs
      The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

      The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

      A look at EUA standards and approvals, unavoidable pitfalls, Operation Warp Speed, FDA’s use of Real-World Evidence, and a slow return to “normalcy.”
      Chad Landmon, Michelle Divelbiss and Alex Alfano, Attorneys - Axinn, Veltrop & Harkrider LLP 01.27.21


    • Excipients
      Bye-Bye China?

      Bye-Bye China?

      Instead of closing its doors on China, Western pharma industry needs to take a balanced approach and perform proper due diligence based on objective criteria.
      Michele Jermini and Enrico Polastro 11.17.20

    • Clinical Trials | Information Technology | R&D
      Decentralized Trials Fuel AI Revolution in Clinical Research

      Decentralized Trials Fuel AI Revolution in Clinical Research

      The life sciences industry is giving clinical a full makeover, dramatically improving how new therapeutics are developed.
      Nick Moss, Vice President of Analytics and Machine Learning, Medable 11.17.20

    • Drug Delivery | Injectables
      Self-Medication: Flexibility for Patients and Drug Manufacturers

      Self-Medication: Flexibility for Patients and Drug Manufacturers

      Bringing together self-medication with auto-injectors and sustainable secondary packaging.
      Matthias Heinrichs, Head of Product Management and Project Engineering, Syntegon Technology 11.17.20


    • The Single-Use Mixing Landscape: Evaluating Your Options

      The Single-Use Mixing Landscape: Evaluating Your Options

      Adoption of single-use technologies has increased markedly in recent years and will continue to grow.
      Mark A. Sitcoske, Founder & CEO, High Purity New England 11.17.20

    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation

      DCAT President Talks COVID-19, Drug Manufacturing and Innovation

      Lonza’s Director of Commercial Development, Sean Diver, was recently named President of DCAT.
      Tim Wright, Editor, Contract Pharma 11.17.20

    • Biologics, Proteins, Vaccines | Biosimilars | Drug Development
      Biopharma Contract Manufacturing: Robust Growth Ahead

      Biopharma Contract Manufacturing: Robust Growth Ahead

      The biopharmaceutical contract manufacturing market is projected to reach $6.3 billion in 2020, and it will continue to grow over the next five years.
      William Downey, HighTech Business Decisions 11.17.20

    Trending
    • BMS Expands Cell Therapy Manufacturing Capabilities
    • AbbVie Opts To Acquire Mitokinin
    • Bormioli Opens New Glass Research Center
    • WuXi AppTec Completes OXGENE Acquisition
    • Arcline Investment Acquires ChargePoint Technology
    Breaking News
    • Fusion Pharmaceuticals Acquires IPN-1087
    • Strata Oncology Unveils Strata PATH Trial
    • Alimentiv Acquires McDougall Scientific
    • Q BioMed Inks Strontium89 Supply Pact
    • PCI Pharma Services Appoints SVP, CFO
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • High Drug Loading Amorphous Solid Dispersions
    • Parenteral Drug Delivery Trends
    • Selecting the Right Outsourcing Model for Emerging Biotech
    • Inhaled Drug Delivery Technology
    • The Future of Biologics: Accelerating Production, Reducing Costs
    • Business Intelligence For (and From) the Lab
    • Communicating Your Contracting Priorities to Your Drug Company Customers
    • COVID-19 Impact Report
    • The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Low Levels of Vitamin D and Calcium Linked to COVID-19 Severity
    Probiotic Evidenced to Assist Digestive Recovery from a Complex Surgery
    AHPA Submits Comments to FDA on Proposed Traceability Rule
    Coatings World

    Latest Breaking News From Coatings World

    Chromaflo Technologies Adds Benjamin Woeste as Territory Sales Manager
    AOC Announces EMEA Price Increase
    Mule-Hide Products Co. Introduces Seal-Fast Liqui-Flash
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    NAMSA Acquires American Preclinical Services
    Quidel's QuickVue At-Home COVID-19 Test Earns EUA
    Memic Receives FDA Marketing Authorization for Hominis
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Fusion Pharmaceuticals Acquires IPN-1087
    Strata Oncology Unveils Strata PATH Trial
    Alimentiv Acquires McDougall Scientific
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    IT Cosmetics Supports Women’s Confidence
    Inter Parfums Reports a Strong Fourth Quarter
    Universal Engraving Announces New President
    Happi

    Latest Breaking News From Happi

    Croda International Acquires Alban Muller
    Givaudan Active Beauty Launches Omegablue
    Sozio Acquires Scentessence
    Ink World

    Latest Breaking News From Ink World

    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Abbott Label installs Domino K600i dual bar digital UV inkjet printer
    Crossmark turns to Eagle Systems for cold foil
    Maxcess launches Tidland PressureMax Airshaft Pressure Monitoring System
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Domtar Completes Sale of Personal Care Business
    Mitsui to Sell Chinese Nonwovens Business
    Dr. J's Disinfectant Wipes Approved for Distribution in CA
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA Approves Accufix Surgical's Accu-Joint Hemi Implant
    FDA OKs Q-Collar Device to Protect Athletes’ Brains During Head Impacts
    SeaSpine Releases Reef TO (TLIF Oblique) Interbody System
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login